Announcements Trials
Browse Landscape

Phase

Phase 2 9Phase 2/3 3Phase 1/2 3Phase NA 2Phase EARLY_PHASE1 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Renal Insufficiency, Chronic 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms 1Myelodysplastic Syndromes 1Lymphoma, Non-Hodgkin 1Lymphoma 1Leukemia, Lymphoid 1Leukemia, Biphenotypic, Acute 1Leukemia 1Hodgkin Disease 1Hematologic Neoplasms 1

Interventions

venetoclax 1ruxolitinib 1isatuximab 1daratumumab 1Tissue Plasminogen Activator 1Therapeutics 1Stem Cell Transplantation 1Psychiatric Rehabilitation 1Oxymorphone 1Oxycodone 1Morphine 1Lisaftoclax 1Levorphanol 1Kidney Transplantation 1Hyperthermia, Induced 1Hydromorphone 1Hydrocodone 1Diathermy 1Counseling 1Cell- and Tissue-Based Therapy 1CF regimen 1Abatacept 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Hematologic Neoplasms × Stem Cell Transplantation × Clear all
NCT07358195 2026-01-22

Addition of Venetoclax to Combined Hematopoietic Stem Cell and Kidney Transplantation

Massachusetts General Hospital

Phase EARLY_PHASE1 Not yet recruiting
3 enrolled
Other hematologic neoplasm

Hematologic Neoplasms, Renal Insufficiency, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡